FFCP PHASE2:Hg19::chr14:21387491..21387506,+
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p2@RNASE2 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_2_at_RNASE2_5end |
Coexpression cluster: | C132_acute_small_Dendritic_Macrophage_CD14_Neutrophils_Monocytederived |
Association with transcript: | 0bp_to_ENST00000258817, NR_033909, uc010aif.2_5end |
EntrezGene: | 643332,6036 |
HGNC: | 10045 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p2@RNASE2 |
---|
0
5
10
15
20
25
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
myeloid cell | 3.21e-18 | 108 |
common myeloid progenitor | 3.21e-18 | 108 |
hematopoietic stem cell | 3.33e-12 | 168 |
hematopoietic cell | 2.01e-11 | 177 |
hematopoietic oligopotent progenitor cell | 2.97e-11 | 161 |
hematopoietic multipotent progenitor cell | 2.97e-11 | 161 |
CD34-positive, CD38-negative hematopoietic stem cell | 1.03e-09 | 1 |
Showing 1 to 7 of 7 entries
Ontology term | p-value | n |
---|---|---|
left cardiac atrium | 2.77e-09 | 1 |
substantia nigra | 5.72e-09 | 1 |
midbrain nucleus | 5.72e-09 | 1 |
regional part of midbrain | 5.72e-09 | 1 |
midbrain | 5.72e-09 | 1 |
presumptive midbrain | 5.72e-09 | 1 |
midbrain neural tube | 5.72e-09 | 1 |
bone marrow | 3.68e-07 | 76 |
Showing 1 to 8 of 8 entries
Ontology term | p-value | n |
---|---|---|
myeloid leukemia | 1.61e-35 | 31 |
leukemia | 8.04e-28 | 39 |
hematologic cancer | 8.56e-21 | 51 |
immune system cancer | 8.56e-21 | 51 |
syndrome | 1.69e-09 | 1 |
Showing 1 to 5 of 5 entries